Modafinil and abnormal bleeding in a young lady with narcolepsy: a case report
Frontiers in Drug Safety and Regulation · 08.06.2026 · 6
DOI: 10.3389/fdsfr.2026.1767644 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Drug Safety and Regulation, online erschienen am 08.06.2026. Verfasst von Albatol N Rashed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Section, Department of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We report the case of a 27-year-old woman with a history of pituitary microadenoma and multiple sclerosis who developed recurrent vaginal bleeding associated with modafinil and methylphenidate use for narcolepsy type 2. The bleeding resolved upon discontinuation of both medications and recurred upon re-exposure. This case highlights a rare but significant adverse effect of stimulant medications and underscores the importance of monitoring in patients with a history of hormonal disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pulmonary Section, Department of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia.
- Pulmonary Section, Sleep Medicine, Department of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia.
- Alfaisal University, Riyadh, Saudi Arabia.
Zitieren
APA
Rashed, A. N., Abdelbasit, A., & Alshahrani, M. (2026). Modafinil and abnormal bleeding in a young lady with narcolepsy: a case report. Frontiers in Drug Safety and Regulation, 6. https://doi.org/10.3389/fdsfr.2026.1767644
Vancouver
Rashed AN, Abdelbasit A, Alshahrani M. Modafinil and abnormal bleeding in a young lady with narcolepsy: a case report. Frontiers in Drug Safety and Regulation. 2026;6. doi:10.3389/fdsfr.2026.1767644
BibTeX
@article{Rashed2026,
author = {Rashed, Albatol N and Abdelbasit, Ahmed and Alshahrani, Mana},
title = {Modafinil and abnormal bleeding in a young lady with narcolepsy: a case report},
journal = {Frontiers in Drug Safety and Regulation},
year = {2026},
volume = {6},
doi = {10.3389/fdsfr.2026.1767644}
}
EUVIMED